Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized study of classic vs simplified leucovorin calcium [folinic acid] and fluorouracil with or without irinotecan in patients aged at least 75 years with advanced colorectal cancer

Trial Profile

Randomized study of classic vs simplified leucovorin calcium [folinic acid] and fluorouracil with or without irinotecan in patients aged at least 75 years with advanced colorectal cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Jun 2017 Results studying the factors associated with safety and efficacy, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
    • 05 Nov 2016 Results evaluating geriatric parameters to determine prgnosis in patients with metastatic colorectal cancer, published in the European Journal of Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top